ClinicalTrials.Veeva

Menu

Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.

C

Centro Cardiologico Monzino

Status

Unknown

Conditions

Carotid Stenosis

Treatments

Device: Carotid Wallstent
Device: Filterwire EZ™
Device: Stent Roadsaver®
Device: MO.MA Ultra

Study type

Interventional

Funder types

Other

Identifiers

NCT02915328
R323/15 - CCM334

Details and patient eligibility

About

Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The intra and/or postprocedural cerebral embolization remains the most frequent complication.

The type of carotid stent and of cerebral protection are the two most important variables potentially affecting the rate of cerebral microembolization. So far there no consensus on the the best stent and cerebral protection.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

significant, unilateral carotid artery stenosis with soft plaque defined as:

  • symptomatic patients: > 1.3 m/sec peak systolic velocity and > 50% diameter stenosis by Doppler ultrasound and < 60 hounsfield unit by CT angiography
  • asymptomatic patients > 2.5 m/sec peak systolic velocity and > 70% diameter stenosis by Doppler ultrasound and < 60 hounsfield unit by CT angiography

Exclusion criteria

  • severe cerebral vasculopathy with cognitive impairment
  • contraindication to double antiplatelet treatment
  • controlateral carotid occlusion

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 4 patient groups

Stent Roadsaver® +Filterwire EZ™
Experimental group
Description:
The arm assess the efficacy of the combination of the stent Roadsaver® with the Filterwire EZ™ protection
Treatment:
Device: Stent Roadsaver®
Device: Filterwire EZ™
Stent Roadsaver® + MO.MA Ultra
Experimental group
Description:
The arm assess the efficacy of the combination of the stent Roadsaver® with the MO.MA Ultra protection
Treatment:
Device: Stent Roadsaver®
Device: MO.MA Ultra
Carotid Wallstent +MO.MA Ultra
Experimental group
Description:
The arm assess the efficacy of the combination of the Carotid Wallstent with the MO.MA Ultra protection
Treatment:
Device: Carotid Wallstent
Device: MO.MA Ultra
Carotid Wallstent + Filterwire EZ™
Experimental group
Description:
The arm assess the efficacy of the combination of the Carotid Wallstent with the Filterwire EZ™ protection
Treatment:
Device: Carotid Wallstent
Device: Filterwire EZ™

Trial contacts and locations

1

Loading...

Central trial contact

Piero Montorsi, MD; Stefano Galli, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems